Noradrenaline and 5-hydroxytryptamine metabolism in six areas of rat brain during post-amphethamine depression.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D003863:Depression / Q000378:metabolism*; D003864:Depression, Chemical; D003913:Dextroamphetamine / Q000494:pharmacology*; D005470:Fluorometry; D006624:Hippocampus / Q000378:metabolism; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D008526:Medulla Oblongata / Q000378:metabolism; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism*; D009647:Normetanephrine / Q000378:metabolism; D011149:Pons / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D013239:Stereotyped Behavior / Q000187:drug effects; D013375:Substance Withdrawal Syndrome; D013788:Thalamus / Q000378:metabolism
D009647:Normetanephrine; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D003913:Dextroamphetamine; D009638:Norepinephrine